Orion Infusion Limited announced earnings results for the third quarter ended March 31, 2021. For the third quarter, the company announced sales was BDT 168.005 million compared to BDT 132.799 million a year ago. Operating income was BDT 16.294 million compared to BDT 13.336 million a year ago. Operating income was BDT 9.171 million compared to BDT 13.336 million a year ago. Operating income was BDT 16.294 million compared to BDT 5.775 million a year ago. Operating income was BDT 9.171 million compared to BDT 5.775 million a year ago. Net income was BDT 6.706 million compared to BDT 4.861 million a year ago. Basic earnings per share from continuing operations was BDT 0.33 compared to BDT 0.24 a year ago. For the nine months, sales was BDT 493.802 million compared to BDT 582.757 million a year ago. Operating income was BDT 31.041 million compared to BDT 62.663 million a year ago. Operating income was BDT 53.801 million compared to BDT 62.663 million a year ago. Operating income was BDT 53.801 million compared to BDT 36.035 million a year ago. Operating income was BDT 31.041 million compared to BDT 36.035 million a year ago. Net income was BDT 22.771 million compared to BDT 28.165 million a year ago. Basic earnings per share from continuing operations was BDT 1.12 compared to BDT 1.38 a year ago.